Khan, M.S.; Jakob, V.; Singh, R.; Rajmani, R.S.; Kumar, S.; Lemoine, C.; Kleanthous, H.; Ringe, R.P.; Dubois, P.M.; Varadarajan, R.
Enhancing Immunogenicity of a Thermostable, Efficacious SARS-CoV-2 Vaccine Formulation through Oligomerization and Adjuvant Choice. Pharmaceutics 2023, 15, 2759.
https://doi.org/10.3390/pharmaceutics15122759
AMA Style
Khan MS, Jakob V, Singh R, Rajmani RS, Kumar S, Lemoine C, Kleanthous H, Ringe RP, Dubois PM, Varadarajan R.
Enhancing Immunogenicity of a Thermostable, Efficacious SARS-CoV-2 Vaccine Formulation through Oligomerization and Adjuvant Choice. Pharmaceutics. 2023; 15(12):2759.
https://doi.org/10.3390/pharmaceutics15122759
Chicago/Turabian Style
Khan, Mohammad Suhail, Virginie Jakob, Randhir Singh, Raju S. Rajmani, Sahil Kumar, Céline Lemoine, Harry Kleanthous, Rajesh P. Ringe, Patrice M. Dubois, and Raghavan Varadarajan.
2023. "Enhancing Immunogenicity of a Thermostable, Efficacious SARS-CoV-2 Vaccine Formulation through Oligomerization and Adjuvant Choice" Pharmaceutics 15, no. 12: 2759.
https://doi.org/10.3390/pharmaceutics15122759
APA Style
Khan, M. S., Jakob, V., Singh, R., Rajmani, R. S., Kumar, S., Lemoine, C., Kleanthous, H., Ringe, R. P., Dubois, P. M., & Varadarajan, R.
(2023). Enhancing Immunogenicity of a Thermostable, Efficacious SARS-CoV-2 Vaccine Formulation through Oligomerization and Adjuvant Choice. Pharmaceutics, 15(12), 2759.
https://doi.org/10.3390/pharmaceutics15122759
